Mersana Therapeutics, Inc.
MRSN
$0.3879
-$0.0121-3.03%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 134.62M | 155.17M | 162.74M | 183.15M | 209.08M |
| Total Receivables | -- | 1.00M | 1.57M | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.28M | 4.39M | 4.65M | 4.39M | 4.97M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 136.90M | 160.56M | 168.96M | 187.54M | 214.06M |
|
|
|||||
| Total Current Assets | 136.90M | 160.56M | 168.96M | 187.54M | 214.06M |
| Net Property, Plant & Equipment | 6.78M | 8.00M | 9.19M | 10.36M | 11.53M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 978.00K | 978.00K | 978.00K | 478.00K | 478.00K |
| Total Assets | 144.66M | 169.53M | 179.13M | 198.37M | 226.06M |
|
|
|||||
| Total Accounts Payable | 4.33M | 2.03M | 3.01M | 3.09M | 7.32M |
| Total Accrued Expenses | 18.96M | 18.63M | 17.78M | 15.65M | 20.85M |
| Short-term Debt | -- | -- | -- | 5.21M | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 16.40M | 15.21M | 11.99M | 3.55M | 5.48M |
| Total Finance Division Other Current Liabilities | 22.76M | 32.43M | 29.40M | 25.91M | 29.99M |
| Total Other Current Liabilities | 22.76M | 32.43M | 29.40M | 25.91M | 29.99M |
| Total Current Liabilities | 62.46M | 68.30M | 62.18M | 53.41M | 63.64M |
|
|
|||||
| Total Current Liabilities | 62.46M | 68.30M | 62.18M | 53.41M | 63.64M |
| Long-Term Debt | 10.95M | 14.00M | 17.05M | 20.10M | 23.15M |
| Short-term Debt | -- | -- | -- | 5.21M | -- |
| Capital Leases | 1.30M | 2.32M | 3.90M | 4.86M | 5.20M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 79.46M | 83.87M | 87.57M | 92.02M | 97.17M |
| Total Liabilities | 154.17M | 168.48M | 170.70M | 170.39M | 189.16M |
|
|
|||||
| Common Stock & APIC | 886.03M | 882.46M | 878.43M | 873.74M | 863.25M |
| Retained Earnings | -895.55M | -881.44M | -869.94M | -845.67M | -826.36M |
| Treasury Stock & Other | 10.00K | 25.00K | -71.00K | -90.00K | 11.00K |
| Total Common Equity | -9.51M | 1.05M | 8.43M | 27.99M | 36.90M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.51M | 1.05M | 8.43M | 27.99M | 36.90M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.51M | 1.05M | 8.43M | 27.99M | 36.90M |
|
|
|||||